Intravitreal bevacizumab for diabetic papillopathy
 
Yazarlar (2)
Prof. Dr. Kemal ÖRNEK Kırıkkale Üniversitesi, Türkiye
Prof. Dr. Tevfik Oğurel Kırıkkale Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Ocular Pharmacology and Therapeutics (Q2)
Dergi ISSN 1080-7683 Dergi Bilgileri (2010)
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 01-2010
Cilt / Sayı / Sayfa 26 / 2 / 217–218 DOI 10.1089/jop.2009.0125
UAK Araştırma Alanları
Göz Hastalıkları
Özet
A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect. Visual field testing showed no significant defect in both eyes. Systemic investigations revealed no abnormality. The patient was injected with bevacizumab intravitreally with the diagnosis of diabetic papillopathy (DP). Three weeks later, the vision increased to 7/10 in the right eye and optic disc edema disappeared. Intravitreal injection of bevacizumab effectively treated DP.
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 10
Scopus 13
Google Scholar 26
Intravitreal bevacizumab for diabetic papillopathy

Paylaş